Ipragliflozin,抑制剂，761423-87-4，97%

中文名：Ipragliflozin,抑制剂

英文名：Ipragliflozin

中文别名：(1S)-1,5-脱水-1-C-[3-[(1-苯并噻吩-2-基)甲基]-4-氟苯基]-D-葡糖醇

英文别名：Ipragliflozin|761423-87-4|suglat|ASP1941|ASP-1941|Ipragliflozin [INN]|Ipragliflozin (ASP1941)|(2S,3R,4R,5S,6R)-2-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol|3N2N8OOR7X|CHEMBL2018096|(1S)-1,5-Anhydro-1-c-[3-[(1-benzot

纯度：97%

货号：I177384

Cas号：761423-87-4

存储温度：-20°C储存

产品介绍：

Ipragliflozin (ASP1941) is a highly potent and selective SGLT2 inhibitor with IC50 of 2.8 nM; little and NO potency for SGLT1/3/4/5/6. IC50 value: 2.8 nM Target: SGLT2 in vitro: Ipragliflozin potently and selectively inhibited human, rat, and mouse SGLT2 at nanomolar ranges and exhibited stability against intestinal glucosidases. in vivo: Ipragliflozin showed good pharmacokinetic properties following oral dosing, and dose-dependently increased urinary glucose excretion, which lasted for over 12 h in normal mice. Oral administration of ipragliflozin increased urinary glucose excretion in a dose-dependent manner, an effect which was significant at doses of 0.3 mg/kg or higher and lasted over 12 h. Single administration of ipragliflozin dose-dependently increased urinary glucose excretion, reduced blood glucose and plasma insulin levels, and improved glucose intolerance .

查看阿拉丁官网此产品相关对应页面：https://www.aladdin-e.com/zh_cn/I177384.html

Ipragliflozin,抑制剂，761423-87-4，97%信息由上海阿拉丁生化科技股份有限公司为您提供，如您想了解更多关于Ipragliflozin,抑制剂，761423-87-4，97%报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途